CLINICAL CASE: NEUROENDOCRINE TUMOR OF THE SMALL INTESTINE - METASTASES IN THE LIVER, PANCREAS AND KINDEY. THE RARITY OF OBSERVATION


Cite item

Full Text

Abstract

Neuroendocrine neoplasms are produced by a unique group of epithelial neoplasias that exhibit common neuroendocrine characteristics and have specific terminology, classification, semiotics, and specific approaches to diagnosis and treatment. Neuroendocrine neoplasms (NEP) are most often found in the gastrointestinal tract (GIT), mainly in the small intestine. The most frequently detected metastases of GIT NEP are metastases in the liver (95%), distant metastases to other organs, such as the pancreas or kidney are extremely rare. Case report: a 45-year-old patient K., who was admitted to the department of tumors of the liver and pancreas of N.N. Blokhin National Medical Research Center of Oncology with the diagnosis of primary-multiple synchronous neoplasms: 1) neuroendocrine tumor of the small intestine G2-Ki 67 = 12% with synchronous bilobar metastases in the liver, under an operation in 2010; 2) left kidney cancer, under an operation in 2011. During the dynamic observation in 2017, lesions in the pancreas, kidney and liver were identified. After the necessary examination, a preliminary diagnosis was made as small intestine neuroendocrine tumors with liver, pancreas and kidney metastases. The patient underwent surgical treatment in the volume of resection of the hook-shaped process of the pancreas with the tumor, distal pancreas resection, splenectomy, liver resection and resection of the right kidney. According to the morphological study, changes in the pancreas, kidney, and liver corresponded with the metastases of the small intestine neuroendocrine tumor. Conclusion: Patients with pancreas and kidney metastases of small intestine neuroendocrine tumors are extremely rare to observe. Surgical therapy can be considered the only radical treatment for this case.

About the authors

Yu. I Patyutko

N.N. Blokhin National Medical Research Center of Oncology

Moscow, 115478, Russian Federation

D. V Podluzhny

N.N. Blokhin National Medical Research Center of Oncology

Moscow, 115478, Russian Federation

Olesya N. Soloveva

N.N. Blokhin National Medical Research Center of Oncology

Email: olesya.soloveva.1983@inbox.ru
Graduate Student of the Surgical Department of Tumors of Liver and Pancreas; Moscow, 115478, Russian Federation Moscow, 115478, Russian Federation

V. A Gorbunova

N.N. Blokhin National Medical Research Center of Oncology

Moscow, 115478, Russian Federation

V. B Matveev

N.N. Blokhin National Medical Research Center of Oncology

Moscow, 115478, Russian Federation

V. V Delektorskaya

N.N. Blokhin National Medical Research Center of Oncology

Moscow, 115478, Russian Federation

N. A Kozlov

N.N. Blokhin National Medical Research Center of Oncology

Moscow, 115478, Russian Federation

Ding Xiaodong

N.N. Blokhin National Medical Research Center of Oncology

Moscow, 115478, Russian Federation

References

  1. Modlin I.M., Lye K.D., Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003; 97(4): 934-59.
  2. Пирогова М.С., Поликарпова С.Б. Результаты хирургического лечения эндокринно-клеточных опухолей желудочно-кишечного тракта. Вестник РГМУ. 2008; 2: 132.
  3. Modlin I.M., Oberg K., Chung D.C. et al. Gastroenteropancreatic neuroendocrine tumors. Lancet Oncol. 2008; 9(1): 61-72. doi: 10.1016/S1470-2045(07)70410-2.
  4. Горбунова В.А. ред. Нейроэндокринные опухоли: общие принципы диагностики и лечения. М.: Кодекс; 2015.
  5. Yao J.C., Hassan M., Phan A., Dagohoy C., Leary C., Mares J.E. et al. One hundred years after ‘carcinoid’: epidemiology of and prog- nostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 2008; 26(18): 3063-72.
  6. Maroun J., Kocha W., Kvols L. et al. Guidelines for the diagnosis and management of carcinoid tumours. Part 1: The gastrointestinal tract. A statement from a canadian national carcinoid expert group. Curr. Oncol. 2006; 13(2): 67-76.
  7. Adler H., Redmond C.E., Heneghan H.M. et al. Pancreatectomy for metastatic disease: A systematic review. Eur. J. Surg. Oncol. 2014; 40(4): 379-86.
  8. Moussa A., Mitry E., Hammel P. et al. Pancreaticmetastases: A multicentric study of 22 patients. Gastroenterol. Clin. Biol. 2004; 28(10 Pt.1): 872-6.
  9. Bleszynski M. Schaeffer D.F., Segedi M. Ileal neuroendocrine tumor metastasis to pancreas and liver: A case report. Int. J. Hepatob. Pancreat. Dis. 2017; 7: 11-4. doi: 10.5348/ijhpd-2017-66-CR-2

Copyright (c) 2018 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies